0001062993-24-011568.txt : 20240531
0001062993-24-011568.hdr.sgml : 20240531
20240531165658
ACCESSION NUMBER: 0001062993-24-011568
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240216
FILED AS OF DATE: 20240531
DATE AS OF CHANGE: 20240531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hamilton Thomas Edward
CENTRAL INDEX KEY: 0001769848
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 241010595
MAIL ADDRESS:
STREET 1: 211 STUYVESANT AVE
CITY: RYE
STATE: NY
ZIP: 10580
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Larimar Therapeutics, Inc.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
BUSINESS PHONE: 844-511-9056
MAIL ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN, INC.
DATE OF NAME CHANGE: 20100301
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-02-16
0001374690
Larimar Therapeutics, Inc.
LRMR
0001769848
Hamilton Thomas Edward
C/O LARIMAR THERAPEUTICS, INC.
THREE BALA PLAZA EAST, SUITE 506
BALA CYNWYD
PA
19004
1
0
0
0
0
Common Stock
2024-02-16
4
P
0
57208
8.74
A
564798
D
Common Stock
159433
I
Post Edison, LLC
Stock Option (Right to Buy)
7.07
2024-05-29
4
A
0
19000
0
A
2034-05-29
Common Stock
19000
19000
D
Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. (the "Company") at the offering price, which closed on February 16, 2024.
The options vest on the earlier of (a) May 29, 2025 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.
/s/ Jennifer Johansson, Attorney-in-fact
2024-05-31